Author:
Fukushima Akihiro,Fukui Arisa,Takemura Yuki,Maeda Yasuhiro,Ono Hideki
Subject
Pharmacology,Molecular Medicine
Reference15 articles.
1. FDA review: Department of Health and Human Services, Public Health Service, Food and Drug Administration, Center for Drug Evaluation and Research, One-year post pediatric exclusivity postmarketing adverse event review, Drug: oseltamivir phosphate, ODS PID# D040223. http://www.fda.gov/ohrms/dockets/ac/05/briefing/2005-4180b_06_01_Tamiflu AE_reviewed.pdf. Published 2005.
2. Oseltamivir, an anti-influenza virus drug, produces hypothermia in mice;Ono;Biol Pharm Bull,2008
3. Reduction in sympathetic nerve activity as a possible mechanism for the hypothermic effect of oseltamivir, an anti-influenza virus drug, in normal mice;Ono;Basic Clin Pharmacol Toxicol,2013
4. Oseltamivir produces hypothermic and neuromuscular effects by inhibition of nicotinic acetylcholine receptor functions: comparison to procaine and bupropion;Fukushima;Eur J Pharmacol,2015
5. Nonclinical pharmacokinetics of oseltamivir and oseltamivir carboxylate in the central nervous system;Hoffmann;Antimicrob Agents Chemother,2009
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献